The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML.
| Image |  |
|---|---|
| Description | scientific article published on 29 May 2012 |
| Author/s |
author: Robert K Hills |
| Publication date | May 29, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |